Guardant Health Announces Results from Blood Test Study for Colorectal Cancer Detection
Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MorePosted by Andy Lundin | Jan 2, 2023 | Colorectal |
Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read MorePosted by Chris Wolski | Dec 29, 2022 | Compliance, Covid 19 |
Certain labs billed Medicare Part B for questionably high levels of add-on tests alongside COVID-19 tests in 2020.
Read MorePosted by Chris Wolski | Dec 28, 2022 | Cancer, Molecular Diagnostic Analyzers |
Researchers are revealing connections between cancer and race or ethnicity with software that infers ancestral roots in tumor DNA and RNA.
Read MorePosted by Chris Wolski | Dec 23, 2022 | Cancer, Sequencing Systems |
Researchers have made an advancement in genetic testing that allows for more accurate prediction of individual’s increased cancer risk.
Read More